Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Reed

Showing results (311-320 of 339) with videos related to

Pageof 34
Sort By:
Journal of Cellular Physiology|July 23, 2013
Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV)Belal M Azab, Rupesh Dash, Swadesh K Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997Michael R Grever, David M Lucas, Gordon W Dewald, et al.
Chemmedchem|April 21, 2009
Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzeneMarcia I Dawson, Mao Ye, Xihua Cao, et al.
Molecular Cancer Therapeutics|January 8, 2010
Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligandsTabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Journal of Cellular Physiology|July 23, 2011
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cellsBelal Azab, Rupesh Dash, Swadesh K Das, et al.
ACS Medicinal Chemistry Letters|October 18, 2011
Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB ActivationPasha M Khan, Ricardo G Correa, Daniela B Divlianska, et al.
The Journal of Biological Chemistry|October 7, 2018
Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain bindingFranklin L Zhong, Kim Robinson, Daniel Eng Thiam Teo, et al.
Gut|February 28, 2014
XIAP variants in male Crohn's diseaseYvonne Zeissig, Britt-Sabina Petersen, Snezana Milutinovic, et al.
Cancer Cell|January 30, 2004
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activityAaron D Schimmer, Kate Welsh, Clemencia Pinilla, et al.
Blood|February 2, 2006
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative studyJane N Winter, Edie A Weller, Sandra J Horning, et al.
Pageof 34

Showing results (311-320 of 339) with videos related to

Sort By:
Pageof 34
Journal of Cellular Physiology|July 23, 2013
Enhanced prostate cancer gene transfer and therapy using a novel serotype chimera cancer terminator virus (Ad.5/3-CTV)Belal M Azab, Rupesh Dash, Swadesh K Das, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 7, 2007
Comprehensive assessment of genetic and molecular features predicting outcome in patients with chronic lymphocytic leukemia: results from the US Intergroup Phase III Trial E2997Michael R Grever, David M Lucas, Gordon W Dewald, et al.
Chemmedchem|April 21, 2009
Derivation of a retinoid X receptor scaffold from peroxisome proliferator-activated receptor gamma ligand 1-Di(1H-indol-3-yl)methyl-4-trifluoromethylbenzeneMarcia I Dawson, Mao Ye, Xihua Cao, et al.
Molecular Cancer Therapeutics|January 8, 2010
Selective inhibition of histone deacetylases sensitizes malignant cells to death receptor ligandsTabitha E Wood, Shadi Dalili, Craig D Simpson, et al.
Journal of Cellular Physiology|July 23, 2011
Enhanced delivery of mda-7/IL-24 using a serotype chimeric adenovirus (Ad.5/3) in combination with the Apogossypol derivative BI-97C1 (Sabutoclax) improves therapeutic efficacy in low CAR colorectal cancer cellsBelal Azab, Rupesh Dash, Swadesh K Das, et al.
ACS Medicinal Chemistry Letters|October 18, 2011
Identification of Inhibitors of NOD1-Induced Nuclear Factor-κB ActivationPasha M Khan, Ricardo G Correa, Daniela B Divlianska, et al.
The Journal of Biological Chemistry|October 7, 2018
Human DPP9 represses NLRP1 inflammasome and protects against autoinflammatory diseases via both peptidase activity and FIIND domain bindingFranklin L Zhong, Kim Robinson, Daniel Eng Thiam Teo, et al.
Gut|February 28, 2014
XIAP variants in male Crohn's diseaseYvonne Zeissig, Britt-Sabina Petersen, Snezana Milutinovic, et al.
Cancer Cell|January 30, 2004
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activityAaron D Schimmer, Kate Welsh, Clemencia Pinilla, et al.
Blood|February 2, 2006
Prognostic significance of Bcl-6 protein expression in DLBCL treated with CHOP or R-CHOP: a prospective correlative studyJane N Winter, Edie A Weller, Sandra J Horning, et al.
Pageof 34